Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CRH PLC T.CRH


Primary Symbol: CRH

CRH PLC is a provider of building materials solutions. The Company integrates building materials, products, and services by providing them to customers as complete solutions. Its segments include Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions and Europe Building Solutions. The Americas Materials Solutions segment provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings in North America. The Americas Building Solutions segment manufactures, supplies, and delivers solutions for the built environment in communities across North America. The Europe Materials Solutions segment provides solutions for the construction of public infrastructure and commercial and residential buildings to customers in construction markets in Europe. The Europe Building Solutions segment combines materials, products, and services to produce a range of architectural and infrastructural solutions.


NYSE:CRH - Post by User

Post by WINDGOD46on Dec 04, 2017 9:38pm
195 Views
Post# 27089938

For what is worth

For what is worth
CRH Medical Corp. (CRH-T) 
Here are two contradictory positions of the so called Analyst, J.D., Vicario. You be the judge.


He was one of the first buyers.  He sold half his position when it was disproportionately high and then the rest on the way down.  The market has lost confidence in management, who also sold a lot of shares in the $7 range.  If it broke through $3.30 on heavy volume he would take a good look but there are better options until then.

biotechnology/pharmaceutical
Jason Del Vicario

Portfolio Manager, HollisWealth

Price: $0.000
Owned: No

Had a tremendous run up to about $12, but got completely blindsided, and it pulled back heavily. Got stopped out around mid-$6. Thinks they are going to be okay long-term. There were some issues with insider selling at higher levels. If you own, continue to hold as it looks like it has bottomed.
biotechnology/pharmaceutical
0   0 0
Jason Del VicarioPortfolio Manager, HollisWealth
Price: $3.190
Owned: 

<< Previous
Bullboard Posts
Next >>